This increased signaling through GRP119, FFAR2/3 and their downstream effects through GLP-1 and SGLT1/GLUT2 mediated by sweet taste receptors represent a potential mechanism for improved glycemic control in diabetes following RYGB gastric bypass. The gene discussed is FFAR2; the disease is diabetes mellitus.